Network origin in Ellen Murray Howe first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Transportation Security Administration
2
| Government | General Government | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ellen Murray Howe via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Georgia Southern University | College/University | Undergraduate Degree | |
| National Defense University | College/University | Graduate Degree | |
Oisin Biotechnologies, Inc.
 Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Methuselah Capital Management LLC
 Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Investment Managers | Chief Executive Officer | |
| ORGANOVO HOLDINGS, INC. | Biotechnology | Director/Board Member | |
Leucadia Therapeutics, Inc.
 Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Leucadia Therapeutics, Inc. develops diagnostic algorithm for Alzheimer disease prevention and treatment. The firm?s therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. The company was founded by Doug Ethell and is headquartered in Delaware. | Medical Specialties | Director/Board Member | |
| Methuselah Foundation | Chief Executive Officer | ||
Turn Biotechnologies, Inc.
 Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA. | Biotechnology | Chairman | |
| Volumetric Biotechnologies, Inc. | Director/Board Member |
Statistics
International
| United States | 10 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Operational
| Director/Board Member | 5 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Most connected contacts
| Insiders | |
|---|---|
| David Gobel | 8 |
| Stephen N. Wood | 3 |
- Stock Market
- Insiders
- Ellen Murray Howe
- Company connections
